Total Payments
$3,631
2024 Payments
$288.47
Companies
33
Transactions
182
Medicare Patients
3,268
Medicare Billing
$233,022
Payment Breakdown by Category
Food & Beverage$3,255 (89.6%)
Research$361.76 (10.0%)
Education$14.52 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,255 | 178 | 89.6% |
| Unspecified | $361.76 | 2 | 10.0% |
| Education | $14.52 | 2 | 0.4% |
Payments by Type
General
$3,269
180 transactions
Research
$361.76
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $711.33 | 24 | $0 (2024) |
| Novo Nordisk Inc | $505.73 | 33 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $321.70 | 10 | $0 (2024) |
| PFIZER INC. | $312.48 | 16 | $0 (2023) |
| Allergan, Inc. | $229.32 | 10 | $0 (2020) |
| Lilly USA, LLC | $203.77 | 14 | $0 (2023) |
| Purdue Pharma L.P. | $158.97 | 5 | $0 (2018) |
| Abbott Laboratories | $148.06 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $120.08 | 9 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $113.13 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.47 | 15 | Novo Nordisk Inc ($76.92) |
| 2023 | $486.17 | 20 | Bayer Healthcare Pharmaceuticals Inc. ($137.48) |
| 2022 | $416.26 | 20 | Bayer HealthCare Pharmaceuticals Inc. ($165.41) |
| 2021 | $182.07 | 12 | Novartis Pharmaceuticals Corporation ($41.90) |
| 2020 | $475.67 | 29 | Novo Nordisk Inc ($148.65) |
| 2019 | $511.02 | 31 | Allergan Inc. ($164.53) |
| 2018 | $460.51 | 27 | PFIZER INC. ($158.84) |
| 2017 | $810.98 | 28 | GlaxoSmithKline, LLC. ($433.18) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Neuromodulation | ||||||
| 08/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.16 | General |
| 08/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.34 | General |
| 05/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Neuromodulation | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Neuromodulation | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Oncology | ||||||
| 01/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: RESPIRATORY | ||||||
| 12/22/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Neuromodulation | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: VACCINES | ||||||
| 10/03/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Inflammation | ||||||
| 07/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes | ||||||
| 06/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Gastroenterology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Clinical Outcomes Study to compare the effect of Fluticasone Furoate Vilanterol Inhalation Powder 100 25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease COPD and a history of or at increased risk for cardiov | GlaxoSmithKline, LLC. | $361.76 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 614 | 893 | $119,446 | $50,050 |
| 2022 | 10 | 830 | 1,179 | $131,723 | $53,946 |
| 2021 | 12 | 956 | 1,353 | $158,105 | $65,091 |
| 2020 | 10 | 868 | 1,260 | $221,281 | $63,934 |
Total Patients
3,268
Total Services
4,685
Medicare Billing
$233,022
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 296 | $50,912 | $21,737 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $30,129 | $14,840 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 188 | $30,456 | $10,244 | 33.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 159 | 239 | $1,673 | $1,621 | 96.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 38 | $3,724 | $1,182 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,552 | $426.42 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 346 | $59,512 | $24,180 | 40.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 129 | 129 | $32,121 | $16,439 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 201 | $32,562 | $10,538 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 37 | $3,626 | $1,127 | 31.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 218 | 361 | $2,527 | $1,067 | 42.2% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 23 | 28 | $616.00 | $268.42 | 43.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 16 | $352.00 | $153.82 | 43.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 23 | 27 | $135.00 | $59.51 | 44.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 17 | $136.00 | $58.62 | 43.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 15 | 17 | $136.00 | $54.79 | 40.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 236 | 380 | $68,646 | $28,379 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 264 | $42,746 | $15,545 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 119 | 119 | $29,631 | $15,389 | 51.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 55 | 58 | $5,684 | $2,230 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 263 | 403 | $2,821 | $1,202 | 42.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 24 | 24 | $5,564 | $1,165 | 20.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 13 | 19 | $1,672 | $607.24 | 36.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $481.00 | $214.11 | 44.5% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 22 | 22 | $484.00 | $213.62 | 44.1% |
About Dr. Dave Webster, DO
Dr. Dave Webster, DO is a Family Medicine healthcare provider based in Killeen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992808018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dave Webster, DO has received a total of $3,631 in payments from pharmaceutical and medical device companies, with $288.47 received in 2024. These payments were reported across 182 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,255).
As a Medicare-enrolled provider, Webster has provided services to 3,268 Medicare beneficiaries, totaling 4,685 services with total Medicare billing of $233,022. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Killeen, TX
- Active Since 09/06/2006
- Last Updated 09/04/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992808018
Products in Payments
- Ozempic (Drug) $327.49
- Kerendia (Drug) $321.70
- VRAYLAR (Drug) $220.38
- EUCRISA (Drug) $147.58
- TRULICITY (Drug) $123.48
- TRELEGY ELLIPTA (Drug) $114.77
- SYMPROIC (Drug) $114.28
- AREXVY (Drug) $87.75
- CHANTIX (Drug) $86.14
- ENTRESTO (Drug) $86.00
- PROCLAIM (Device) $79.61
- Rybelsus (Drug) $77.61
- SHINGRIX (Biological) $75.63
- Trintellix (Drug) $72.97
- ANORO (Drug) $71.42
- AIRSUPRA (Drug) $64.57
- XIFAXAN (Drug) $58.99
- Prolia (Biological) $58.59
- INTELLIS ADAPTIVESTIM (Device) $50.65
- MOUNJARO (Drug) $44.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Killeen
Ernesto Malave, M.d, M.D
Family Medicine — Payments: $9,636
Family Medicine $9,636
Dr. Paula Lansford-Seabaugh, D.o, D.O
Family Medicine — Payments: $6,665
Family Medicine $6,665
Riesa Klapproth, M.d, M.D
Family Medicine — Payments: $1,196
Family Medicine $1,196
Dr. Jeremy Swain, D.o, D.O
Family Medicine — Payments: $900.48
Family Medicine $900.48
Dr. Charles Mitchell, M.d, M.D
Family Medicine — Payments: $690.63
Family Medicine $690.63
Dr. Michael Oneal, D.o, D.O
Family Medicine — Payments: $392.48
Family Medicine $392.48